![Dylan Wenke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dylan Wenke
Corporate Officer/Principal bei
CNS PHARMACEUTICALS, INC.
Profil
Mr. Dylan Wenke is a Chief Business Officer at CNS Pharmaceuticals, Inc. Mr. Wenke was previously employed as a Director-Business Development by Corbus Pharmaceuticals Holdings, Inc. He received his undergraduate degree from the University of North Florida.
Aktive Positionen von Dylan Wenke
| Unternehmen | Position | Beginn |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.03.2026 |
Ehemalige bekannte Positionen von Dylan Wenke
| Unternehmen | Position | Ende |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Corporate Officer/Principal | 01.11.2021 |
Ausbildung von Dylan Wenke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of North Florida
 University of North Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
